SCHEMBL5033102

SCHEMBL5033102

N[C@@H](CO)C(=O)O[C@H]1[C@@H](OC[C@H]2O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]2O)O[C@H](CO)[C@H](O)[C@@H]1O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CD209 Q9NNX6 2/20 0.47
CA2 P00918 1/20 0.44
IGF2R P11717 2/20 0.39
GAA P10253 1/20 0.38
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
AMY2A P04746 2/20 0.36
PRKD3 O94806 1/20 0.36
PRKCG P05129 1/20 0.36
PRKCB P05771 1/20 0.36
PRKCA P17252 1/20 0.36
PRKCH P24723 1/20 0.36
PRKCI P41743 1/20 0.36
PRKCE Q02156 1/20 0.36
PRKCQ Q04759 1/20 0.36
PRKCZ Q05513 1/20 0.36
PRKCD Q05655 1/20 0.36
PRKD1 Q15139 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18191573 0.81 CA2 (0.46) CD209CA2IGF2RGAACDK1
SCHEMBL2233863 0.81 CA2 (0.45) CD209CA2IGF2RGAACDK1
SCHEMBL1066087 0.79 L3MBTL1 (0.41) IGF2RGAAPRKD3PRKCGPRKCB
SCHEMBL1458867 0.79 L3MBTL1 (0.41) IGF2RGAAPRKD3PRKCGPRKCB
SCHEMBL8331449 0.79 L3MBTL1 (0.41) IGF2RGAAPRKD3PRKCGPRKCB
SCHEMBL9442810 0.76 CA2 (0.47) CD209CA2IGF2RGAACDK1
SCHEMBL3896598 0.75 CA2 (0.46) CD209CA2IGF2RGAACDK1
SCHEMBL11417663 0.75 CD209 (0.60) CD209CA2IGF2RGAACDK1
SCHEMBL11225619 0.75 CD209 (0.60) CD209CA2IGF2RGAACDK1
SCHEMBL4155795 0.75 CD209 (0.60) CD209CA2IGF2RGAACDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1978987-A2 METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM University of Utah Research Foundation (US) 2008-10-15 EP disclosed
WO-2007081792-A2 METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2007-07-19 WO disclosed